When up against aggressive development timelines and technical milestones, access to additional methods of generating bioprocessing data can significantly accelerate the speed of drug development. This case study describes a successful collaboration between Cytovance Biologics and Culture Biosciences, where fermentation process was transferred, downscaled, modified and improved via a Design of Experiment (DoE), then verified and transferred back to Cytovance Biologics in just a few experiments.
Download to learn how Cytovance Biologics:
- expanded their internal capacity working with Culture's on-demand Cloud Bioreactor Lab
- increased their titer two-fold over the course of six experimental runs
